MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RANI has $58,621K in assets. $17,109K in debts. $18,618K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
420.88%
Quick Ratio
420.88%
Cash Ratio
146.96%
Debt to Asset Ratio
29.19%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Accounts receivable
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Non-controlling interest
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
18,618
Accounts receivable
2,042
Contract asset
0
Marketable securities
31,091
Prepaid expenses and other current assets
1,570
Total current assets
53,321
Property and equipment, net
736
Operating lease right-of-use asset
4,318
Other assets
246
Total assets
58,621
Accounts payable
309
Accrued expenses and other current liabilities
3,943
Current portion of deferred revenue
6,831
Current portion of long-term debt
0
Current portion of operating lease liability
1,586
Total current liabilities
12,669
Long-term deferred revenue
1,708
Long-term debt, less current portion
0
Operating lease liability, less current portion
2,732
Total liabilities
17,109
Common stock, value-Common Class A
9
Common stock, value-Common Class B
2
Common stock, value-Common Class C
0
Additional paid-in capital
165,578
Accumulated other comprehensive gain
1
Accumulated deficit
-132,580
Total stockholders' equity attributable to rani therapeutics holdings, inc
33,010
Non-controlling interest
8,502
Total stockholders' equity
41,512
Total liabilities and stockholders' equity
58,621
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$31,091K Cash and cashequivalents$18,618K Accounts receivable$2,042K Prepaid expenses andother current assets$1,570K Total current assets$53,321K Operating leaseright-of-use asset$4,318K Property and equipment,net$736K Other assets$246K Total assets$58,621K Total liabilities andstockholders' equity$58,621K Total stockholders'equity$41,512K Total liabilities$17,109K Total stockholders'equity attributable to...$33,010K Non-controlling interest$8,502K Total currentliabilities$12,669K Operating leaseliability, less current...$2,732K Long-term deferredrevenue$1,708K Accumulated deficit-$132,580K Additional paid-in capital$165,578K Current portion ofdeferred revenue$6,831K Accrued expenses andother current...$3,943K Current portion ofoperating lease liability$1,586K Accounts payable$309K Common stock,value-Common Class A$9K Common stock,value-Common Class B$2K Accumulated othercomprehensive gain$1K

Rani Therapeutics Holdings, Inc. (RANI)

Rani Therapeutics Holdings, Inc. (RANI)